文献速递产科母胎医学

22 0/7至23 6/7周活产剖宫产利用的当代趋势

Contemporary Trends in Cesarean Delivery Utilization for Live Births Between 22 0/7 and 23 6/7 Weeks of Gestation.
PubMed 文献 · Obstet Gynecol · 2019-01-01

该研究基于美国2012-2013年与2015-2016年两个时间段的单胎活产数据,评估围存活期出生执行摘要发布前后剖宫产率的变化。结果显示剖宫产率从24.3%升至28.4%,主要因23周剖宫产增加,同时新生儿综合干预率上升,新生儿死亡率略有下降。

要点

  • 执行摘要发布后,22-23周单胎活产剖宫产率由24.3%升至28.4%。
  • 23周剖宫产率由36.3%升至40.8%,差异4.5%。
  • 新生儿综合干预率由50.6%升至56.9%,新生儿死亡率由67.2%降至64.6%。

核心结论

  • 围存活期出生执行摘要发布后,23周剖宫产频率增加4.5%。
  • 剖宫产和新生儿综合干预的增加与新生儿死亡率的小幅降低相关。

研究设计与样本

  • 基于美国2012-2013年(执行摘要发布前)和2015-2016年(发布后)所有22 0/7至23 6/7周单胎活产的基于人群的队列研究。
  • 共纳入14,799例单胎活产,其中Epoch 1为7,374例(52.3%),Epoch 2为7,425例(47.7%)。
  • 采用多变量逻辑回归估计分娩时期与结局的关联。

主要发现

  • 剖宫产率从Epoch 1的24.3%升至Epoch 2的28.4%(P<.001)。
  • 23周剖宫产率从36.3%升至40.8%,差异4.5%(95% CI 2.3-6.6)。
  • 新生儿综合干预率从50.6%升至56.9%,差异6.3%(95% CI 4.6-8.0)。
  • 新生儿死亡率从67.2%降至64.6%(P=.009)。
  • 产妇综合不良结局在Epoch 1为8.9%,Epoch 2为9.5%(P=.261),无统计学显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In 2014, the Society for Maternal-Fetal Medicine, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the American Academy of Pediatrics, and the American College of Obstetricians and Gynecologists published an executive summary of a joint workshop to establish obstetric interventions to be considered for periviable births. We sought to evaluate changes in practice patterns since the publication of these guidelines. METHODS: We conducted a population-based cohort study of all singleton live births delivered between 22 0/7 and 23 6/7 weeks of gestation in the United States within two time epochs: pre-executive summary (Epoch 1: 2012-2013) and post-executive summary (Epoch 2: 2015-2016) guideline release. The primary outcome was the difference in the rate of cesarean delivery between pre-executive summary and post-executive summary guideline publication. Secondary outcomes included differences in rates of individual and composite neonatal interventions (neonatal intensive care unit admission, ventilation, surfactant and antibiotic administration), maternal adverse outcomes (intensive care unit admission, transfusion, hysterectomy, uterine rupture), and neonatal mortality. Multivariable logistic regression estimated the association of delivery epoch with outcomes. RESULTS: There were 15,846,405 live births in the United States between 2012-2013 and 2015-2016, of which 14,799 (0.1%) were singletons delivered between 22 and 24 weeks of gestation. Among these live births, 7,374 (52.3%) were delivered in Epoch 1 and 7,425 (47.7%) in Epoch 2. Cesarean delivery rates increased from Epoch 1 to Epoch 2 (24.3% vs 28.4%, P<.001), which was attributable to increased cesarean utilization during the 23rd week (36.3% vs 40.8%, difference 4.5%, 95% CI 2.3-6.6). Likewise, the rate of composite neonatal interventions increased (50.6% vs 56.9%, difference 6.3%, 95% CI 4.6-8.0) between Epochs 1 and 2, in association with a slight reduction in neonatal mortality (67.2% vs 64.6%, P=.009). There was no statistically significant difference in composite (8.9% vs 9.5%, P=.261) adverse maternal outcomes between delivery epochs. CONCLUSION: The frequency of delivery by cesarean in the 23rd week increased by 4.5% after publication of the periviable birth executive summary. The observed increase in cesarean delivery and composite neonatal interventions between delivery cohorts was associated with a small reduction in neonatal mortality.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Rossi RM, Hall E, DeFranco EA, et al. Contemporary Trends in Cesarean Delivery Utilization for Live Births Between 22 0/7 and 23 6/7 Weeks of Gestation. Obstet Gynecol. 2019. PMID: 30741810. doi:10.1097/AOG.0000000000003106

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。